Aarti Pharmalabs Share Price Hits Fresh 52-Week High at Rs 940: Key Reasons Behind the Rally

Published: 23 September 2026 at 9:48 AM IST

Aarti Pharmalabs Share Price moved to Rs 938.10, up 6.17% from the previous close, and set a fresh 52-week high of Rs 939.90. The company now carries a market capitalisation of Rs 7,675.59 crore. For readers tracking Aarti Pharmalabs Share Price Today, the session also matters because the move was accompanied by a full-day range that kept the stock near the top of its session. Aarti Pharmalabs Stock News is therefore centred on the fresh yearly high itself, while the supplied data confirms the price event and the key valuation backdrop. Univest is tracking the same data points that market participants follow in such cases: price, sector context, peer comparison and core financial ratios.

Aarti Pharmalabs Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 938.1
Previous Close	Rs 883.55
Today's Move	+Rs 54.55 (+6.17%)
Open	Rs 885.2
High	Rs 939.9
Low	Rs 885.2
Turnover	Rs 3.32 crore
Market Capitalisation	Rs 7,675.59 crore

Aarti Pharmalabs Ltd. (AARTIPHARM) traded at Rs 938.1 versus the previous close of Rs 883.55, a rise of 6.17%. The stock opened at Rs 885.2, reached a high of Rs 939.9 and touched a low of Rs 885.2.

Aarti Pharmalabs Share Price Today opened at Rs 885.20, matched the day low at Rs 885.20 and advanced to Rs 939.90, which was also the fresh 52-week high. The stock ended at Rs 938.10 versus the previous close of Rs 883.55, translating into a gain of Rs 54.55 or 6.17%. The day’s top and the yearly high were the same figure, which makes this a clean fresh 52-week high event rather than a routine intraday swing.

Turnover stood at Rs 3.32 crore. On a day like this, Aarti Pharmalabs Share Price News is mainly about the verified price event and the exact session data, not about any unverified company-specific trigger. The supplied numbers confirm that the stock finished very close to the peak of the day and at a fresh 52-week high, which is the central fact behind the move. For readers following Aarti Pharmalabs Share Price Live and Aarti Pharmalabs Share Price Update on Univest, the focus remains the day’s price range and the fresh yearly high.

Aarti Pharmalabs Ltd. (AARTIPHARM) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 7,675.59 crore
P/E Ratio	37.59x
P/B Ratio	3.66x
ROE	8.5%
ROCE	10.77%
EPS	Rs 23.51
Book Value Per Share	Rs 241.54
Dividend Yield	0.4%

Aarti Pharmalabs Ltd. (AARTIPHARM) fundamental metrics show P/E 37.59x, P/B 3.66x, ROE 8.5%, ROCE 10.77%. These figures provide context only and are not a buy or sell signal.

Aarti Pharmalabs Ltd. has a market capitalisation of Rs 7675.59 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 37.59x, P/B at 3.66x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 8.5% and ROCE of 10.77%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 23.51, book value per share of Rs 241.54, dividend yield of 0.4%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 31.63x, median ROE of 11.7%, median ROCE of 13.61%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	37.59x
Benchmark Median P/E	31.63x
Benchmark Average P/E	49.61x
Benchmark P/E Range	3.48x to 765.12x
Company P/B Ratio	3.66x
Benchmark Median P/B	2.98x
Company ROE	8.5%
Benchmark Median ROE	11.7%
Company ROCE	10.77%
Benchmark Median ROCE	13.61%
Company Market Capitalisation	Rs 7,675.59 crore
Benchmark Median Market Cap	Rs 718.76 crore

Aarti Pharmalabs Ltd. (AARTIPHARM) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Aarti Pharmalabs Ltd. (AARTIPHARM) has a P/E ratio of 37.59x, which is above the benchmark median of 31.63x, a difference of +18.84%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Aarti Pharmalabs Ltd. (AARTIPHARM) has a ROE of 8.5%, which is below the benchmark median of 11.7%, a difference of -27.35%. Aarti Pharmalabs Ltd. (AARTIPHARM) has a ROCE of 10.77%, which is below the benchmark median of 13.61%, a difference of -20.87%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Supriya Lifescience Ltd.	SUPRIYA	7,541.24	38.02	6.17	19.06	25.3
SYMBIOTEC PHARMALAB LTD	SYMBIOTEC	7,443.75	65.56	4.85	11.22	12.41
Sanofi India Ltd.	SANOFI	7,087.56	21.74	8.52	44.5	55.46
Bliss GVS Pharma Ltd.	BLISSGVS	6,991.76	53.9	5.95	12.11	17.4
Innova Captab Ltd.	INNOVACAP	6,852.4	44.78	6.17	13.75	15.04

Aarti Pharmalabs Ltd. (AARTIPHARM) has a P/E ratio of 37.59x compared with the displayed peer median of 44.78x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 8.5% compares with a peer median of 13.75% across the companies shown in the table. ROCE stood at 10.77% versus the displayed peer median of 17.4%, providing a capital-efficiency comparison. Aarti Pharmalabs Ltd. (AARTIPHARM) has a market capitalisation of Rs 7,675.59 crore. Among the 5 peers shown, 0 have a larger market capitalisation.

Why Investors Are Watching Aarti Pharmalabs

• The stock closed at Rs 938.10 after rising 6.17% from the previous close of Rs 883.55.
• The session high of Rs 939.90 matched the fresh 52-week high for Aarti Pharmalabs Share Price.
• Market capitalisation stood at Rs 7,675.59 crore on the reported data.
• EPS was Rs 23.51, book value was Rs 241.54 and dividend yield was 0.4%.
• ROE of 8.5% and ROCE of 10.77% were below the same-industry medians in the sector snapshot.

About Aarti Pharmalabs

Aarti Pharmalabs Ltd. operates in Healthcare and the Pharmaceuticals & Drugs industry. The supplied data frames the company through price action, market capitalisation, earnings measures and return ratios rather than a detailed business description. For readers following Aarti Pharmalabs Share Price and Aarti Pharmalabs Company News, the most relevant verified context in this update is the sector classification, the listed financial metrics and the fresh 52-week high.

Track Aarti Pharmalabs Share Price on Univest

Use Aarti Pharmalabs Ltd. (AARTIPHARM) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.

You can track Aarti Pharmalabs Share Price on Univest for live price updates, market capitalisation, valuation ratios, shareholding pattern, 52-week levels and company-specific market insights. Univest also keeps Aarti Pharmalabs Stock News and Aarti Pharmalabs Latest News in one place for quick review.

Frequently Asked Questions

Why did Aarti Pharmalabs Share Price hit a fresh 52-week high?

Ans. The supplied data shows Aarti Pharmalabs Share Price rose to Rs 938.10 and touched Rs 939.90, which was the fresh 52-week high. The data confirms the price event but does not establish a company-specific catalyst.

What was Aarti Pharmalabs Share Price today?

Ans. Aarti Pharmalabs Share Price ended at Rs 938.10, up Rs 54.55 or 6.17% from the previous close of Rs 883.55. The day’s high was Rs 939.90 and the low was Rs 885.20.

What is the market capitalisation of Aarti Pharmalabs?

Ans. Aarti Pharmalabs has a market capitalisation of Rs 7,675.59 crore in the supplied data. That places the company within the same-industry benchmark set used in the sector comparison, alongside other listed pharmaceuticals and drugs peers.

How does Aarti Pharmalabs compare on valuation?

Ans. The company’s P/E ratio is 37.59 and P/B ratio is 3.66. Both sit above the industry medians of 31.63 and 2.98, while remaining below the highest values seen in the supplied peer set.

What do EPS, book value and dividend yield show for Aarti Pharmalabs?

Ans. EPS is Rs 23.51, book value is Rs 241.54 and dividend yield is 0.4%. These figures give context to Aarti Pharmalabs Share Price by showing earnings per share, accounting net worth per share and historical payout yield.

How do ROE and ROCE compare with the industry benchmark?

Ans. Aarti Pharmalabs reports ROE of 8.5% and ROCE of 10.77%. Both are below the same-industry medians of 11.7% and 13.61%, so the return profile is weaker than the benchmark median on the supplied data.

How does Aarti Pharmalabs compare with peers on market cap?

Ans. The company’s market cap of Rs 7,675.59 crore is above Supriya Lifescience, SYMBIOTEC PHARMALAB, Bliss GVS Pharma, Innova Captab and Morepen Laboratories in the supplied peer list, and below Procter & Gamble Health.